← HIMS Overview
10-QMay 11, 20265/11/26· Quarter Ended March 31, 2026· Q-End 3/31/26
HIMS — 10-Q Filing
Track for AlertsHIMS 10-Q Summary
For the quarter ended March 31, 2026, Hims & Hers Health, Inc. reported revenue of $608,104, up 3.8% versus the same quarter one year earlier. Operating income swung to a loss of $78,323 from a profit of $57,897 a year earlier, primarily reflecting depreciation & amortization more than doubling to $21,953 and transaction / acquisition costs more than doubling to $6,367; net income was $49,485, essentially flat year-over-year.
HIMS Financial Highlights
What's Driving the Change
HIMS Legal Proceedings Disclosed
Securities / ShareholderRegulatory / Enforcement
Extracted from HIMS’s 10-Q filed May 11, 2026. The text below is the company’s own disclosure language; DredgeCap has not paraphrased, classified, or summarized it.
Disclosure:Legal proceedings described above may contain allegations that have not been proven. Filings often disclose claims that are later dismissed, settled, or resolved without admission of wrongdoing. DredgeCap surfaces the company’s own disclosure language for investor-risk research only. This is not legal advice or investment advice.
Current DredgeCap Risk Profile
5.8/10
ELEVATED RISK
Dilution Risk
MODERATE4.5/10
Liquidity Risk
LOW2.5/10
Debt Toxicity
MODERATE3.0/10
Profitability Risk
ELEVATED6.5/10
Going Concern✓ Not flagged
The risk profile above reflects the latest cached DredgeCap analysis for HIMS. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open HIMS's company page.
What is a 10-Q?
A quarterly report covering the three months just ended. Includes unaudited condensed financial statements (balance sheet, income statement, cash flow), Management Discussion and Analysis (MD&A), and disclosure of material changes since the last annual report. Required for the first three fiscal quarters; the fourth quarter is rolled into the 10-K.
Financial highlights are sourced directly from the 10-Q income statement (three months ended). YoY % compares to the same quarter one year earlier as reported by the issuer. The plain-language summary above is composed mechanically from the filing's reported numbers — no analysis or opinion. Form-type explainers and 8-K item descriptions are derived from SEC documentation. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.